Clearbridge Investments, LLC Neurocrine Biosciences Inc Transaction History
Clearbridge Investments, LLC
- $110 Billion
- Q1 2025
A detailed history of Clearbridge Investments, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Clearbridge Investments, LLC holds 342,302 shares of NBIX stock, worth $42.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
342,302
Previous 319,299
7.2%
Holding current value
$42.1 Million
Previous $43.6 Million
13.14%
% of portfolio
0.03%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.2MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.75 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.22 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$681 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$598 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$329 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...